Open for inclusion

A Phase I/II Dose Escalation Study to Assess the Safety, Tolerability and Efficacy of AmphinexTM induced Photochemical Internalisation (PCI) of Gemcitabine followed by Gemcitabine/ Cisplatin Chemotherapy in Patients with Advanced Inoperable Cholangioca

Cancer type: Cholangiocarcinoma

Phase: I/II

Principal Investigator: Dueland Svein

Country: NO

Keywords: Norway, Oslo, Adenocarcinoma consistent with advanced and inoperable cholangiocarcinoma

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT01900158?term=2012-002888-10&rank=1